Contribution of Limited Molecular Testing to Low Ehrlichiosis Diagnosis in High Incidence Area, North Carolina, USA
Emerging Infectious Diseases · 2025-02 · 31 (2)
DOI: 10.3201/eid3102.240281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-02. Verfasst von Alexis M Siegler und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ehrlichiosis, Molecular Diagnostic Techniques, Ehrlichia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCEZID CDC HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Förderung
- NCEZID CDC HHS
- NCATS NIH HHS
Zitieren
APA
Siegler, A. M., Ursery, L., Giandomenico, D. A., Miller, M. B., Salzer, J. S., Barbarin, A. M., Williams, C., & Boyce, R. M. (2025). Contribution of Limited Molecular Testing to Low Ehrlichiosis Diagnosis in High Incidence Area, North Carolina, USA. Emerging Infectious Diseases, 31(2). https://doi.org/10.3201/eid3102.240281
Vancouver
Siegler AM, Ursery L, Giandomenico DA, Miller MB, Salzer JS, Barbarin AM, et al. Contribution of Limited Molecular Testing to Low Ehrlichiosis Diagnosis in High Incidence Area, North Carolina, USA. Emerging Infectious Diseases. 2025;31(2). doi:10.3201/eid3102.240281
BibTeX
@article{Siegler2025,
author = {Siegler, Alexis M and Ursery, Lauryn and Giandomenico, Dana A and Miller, Melissa B and Salzer, Johanna S and Barbarin, Alexis M and Williams, Carl and Boyce, Ross M},
title = {Contribution of Limited Molecular Testing to Low Ehrlichiosis Diagnosis in High Incidence Area, North Carolina, USA},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {2},
doi = {10.3201/eid3102.240281}
}
EUVIMED